Modifying Radioactive Injection Techniques May Decrease Extravasation Rate
A study aimed to determine the variables that correlated with extravasation rates in patients receiving radiation injection therapy.
Related Articles
AACR Annual Meeting
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
CHMP Recommends Brentuximab Vedotin/Chemo in Advanced Hodgkin Lymphoma
Results from the phase 3 HD21 trial showed that brentuximab vedotin plus chemotherapy was superior to alternative treatments in Hodgkin lymphoma.
Programme – BSH 2024
BSH 2024 will include the key pillars that have stood the programme in good stead for many years – outstanding plenary speakers, a wide range…
OncLive – Clinical Oncology News, Cancer Expert Insights
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
Targeted Oncology – Immunotherapy, Biomarkers, and Cancer Pathways
Targeted Oncology provides news, videos, and reviews on the rapidly evolving world of targeted therapies and immunotherapy for oncologists treating patients in a community setting.
Welcome! You are invited to join a webinar: SSO & AAES & NANETS VTB: Multidisciplinary Management of Neuroendocrine Liver Metastases Virtual Tumor Board. After registering, you will receive a confirmation email about joining the webinar.
Welcome! You are invited to join a webinar: SSO & AAES & NANETS VTB: Multidisciplinary Management of Neuroendocrine Liver Metastases Virtual Tumor Board. After registering,…
Chemoradiation Prolongs OS, Maintains QOL in Advanced Gallbladder Cancers
Chemoradiotherapy resulted in lower incidence of local progression, prompting an evaluation of resectability in patients with advanced gallbladder cancers.
CA: A Cancer Journal for Clinicians Now Accepting Phase III Research
CA: A Cancer Journal for Clinicians publishes information about the prevention, early detection, and treatment of cancer, as well as nutrition, palliative care, survivorship, and…
AACR Annual Meeting
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
FDA Rejects Breakthrough Designation, Approval for Itolizumab in Acute GVHD
Based on FDA feedback, the developers plan to discontinue the phase 3 EQUATOR study, which evaluated itolizumab in acute graft-versus-host disease.